Virtu Financial’s AEON Biopharma Inc AEON.WS Stock Holding History

Virtu Financial’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,000	Closed	-$2K	–	2097
2023 Q2	$2K	Buy	+18,000	New	+$1.35K	﹤0.01%	1429

Other funds holding AEON.WS

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial's AEON.WS Position: Q3 2023 in Review

Virtu Financial sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 18,000 shares — an estimated $2K sold.

Virtu Financial first reported a position in AEON.WS in Q2 2023 and held it in 1 quarter. The position peaked at $2K in Q2 2023. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

Virtu Financial reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 18,000 AEON Biopharma Inc shares in Q3 2023, an estimated $2K.
Virtu Financial first reported a position in AEON Biopharma Inc in Q2 2023 and held it in 1 quarter.
Virtu Financial's AEON Biopharma Inc position peaked at $2K in Q2 2023.
40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.